جستجوی استاد راهنمای دانشگاهی

Professor Maria Craig is a distinguished academic and researcher at the University of New South Wales, Faculty of Medicine & Health, specializing in childhood diabetes research. She holds a prominent position as a Professor with extensive contributions to the field of pediatric endocrinology and diabetes, particularly focusing on type 1 diabetes in children. Professor Craig's educational background includes: MB BS from the University of Melbourne MMedSc(ClinEpid) from the University of Newcastle PhD from the University of Sydney FRACP (Fellow of the Royal Australasian College of Physicians) Professor Craig's research primarily focuses on childhood diabetes, with special emphasis on prediction and prevention of type 1 diabetes. She has a significant interest in the association between viruses and type 1 diabetes, collaborating with the Virology Research Group at Prince of Wales Hospital (POWH). Together with Professor Bill Rawlinson, she leads the viral theme for the multicentre ENDIA study (endia.org.au). As principal investigator for the CoRD trial, she is conducting a world-first phase 1 study using autologous cord blood for prevention of type 1 diabetes in children with islet autoimmunity. Additionally, she serves as principal investigator for the Australasian Diabetes Data Network (ADDN). Her research portfolio also encompasses the epidemiology of various forms of childhood diabetes (type 1, type 2, cystic fibrosis related diabetes and monogenic diabetes) and diabetes complications, in collaboration with Professor Kim Donaghue at the Children's Hospital at Westmead. Professor Craig's extensive publication record, including over 361 journal articles, demonstrates her leadership in advancing our understanding of childhood diabetes. Her recent work shows increasing focus on early detection methods, risk prediction models, technological interventions for diabetes management, and the complex interplay between viral infections and autoimmune diabetes development. She has been instrumental in developing clinical practice guidelines through her role as co-editor of the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Professor Craig has received numerous prestigious awards recognizing her contributions to pediatric endocrinology and diabetes research: Australian Paediatric Endocrine Group Young Investigator's Award (1997) Asia Pacific Paediatric Endocrine Society Clinical Teaching Award (2008) Lifetime Honorary Member, Caring and Living as Neighbours (2013) Australian Diabetes Society Jeff Flack Diabetes Data Award (2019) Australian Paediatric Endocrine Group Norman Wettenhall Award for Research and Innovation (2019) Throughout her career, Professor Craig has demonstrated exceptional leadership in professional societies, having served as former president/treasurer of the Australasian Paediatric Endocrine Group (APEG) and currently as Scientific Convenor of the Asia Pacific Paediatric Endocrine Society Fellows school. Her work with the ENDIA study and Australasian Diabetes Data Network represents significant collaborative research efforts involving multiple institutions across Australia and internationally. Her principal investigator roles for major studies indicate substantial research funding support. Professor Craig leads several important research initiatives including the ENDIA study, the CoRD trial, and the Australasian Diabetes Data Network. These programs involve multidisciplinary teams of researchers, clinicians, and support staff working collaboratively to advance understanding and treatment of childhood diabetes. Her work at the intersection of virology and diabetes represents a unique and innovative approach to understanding the environmental triggers of type 1 diabetes.

• Childhood Diabetes
• Type 1 Diabetes
• Virology and Diabetes
• +۴ مورد دیگر

Karen Piper Hanley is Professor of Molecular Medicine and Head of Division in the Division of Diabetes, Endocrinology & Gastroenterology at the University of Manchester. She serves as the fibrosis lead in the Wellcome Trust Centre for Cell-Matrix Research and previously served as Director of Core Research Technologies (2019-2022). She is also an editorial board member for Scientific Reports. Her research focuses on fibrosis (scarring) mechanisms across multiple organs, particularly liver, kidney, and lung fibrosis. Her lab investigates the cellular and molecular basis of fibrotic disease, with emphasis on how pathological scar components are produced and how they signal to surrounding cells. Key areas include the role of SOX9 transcription factor, integrin beta-1 signaling, Group 1 PAKs, and YAP1 in fibrosis progression. Her recent publications reveal trends toward increased clinical translation of fibrosis research, with studies on health inequalities in liver cancer care, post-COVID diabetes incidence, and innovative approaches to liver disease detection. Her work increasingly integrates spatial transcriptomics and advanced omics technologies to understand cellular transitions in liver disease. Career-track postdoctoral fellowship from the University of Southampton (2006) As senior postgraduate tutor, she has mentored numerous PhD students who have presented at key conferences and authored high-quality manuscripts. All her PhD students have submitted and been awarded their degrees within 4 years. She has successfully guided previous Academic Clinical Fellows to win MRC clinical training fellowships. Her teaching extends to undergraduate Personal & Professional Development and supervision of MRes and BSc students, many of whom have achieved first-class degrees and prestigious awards. Her lab maintains active collaborations with Professor Neil Hanley's group on human development, stem cells, and regenerative medicine, bridging developmental biology with fibrosis research to understand why regeneration is impaired in chronic diseases.

• Fibrosis Research
• Liver Fibrosis
• Kidney Fibrosis
• +۹ مورد دیگر

Akhil Chawla, MD is a Clinical Assistant Professor in the Department of Surgery (Surgical Oncology) at Northwestern University Feinberg School of Medicine and Vice Chair of Regional Integration for the Department of Surgery. He leads the Robert H. Lurie Comprehensive Cancer Center and directs key initiatives such as the Northwestern Medicine Pancreatic Cyst and High-Risk Clinic. His roles include Director of Surgical Oncology for the South Region and Director of Oncology Research in the West Region. Education & Training: BS and MD from the University of Cincinnati (2006–2010). Surgical training includes residencies at Case Western Reserve University (2017), and fellowships at MD Anderson Cancer Center (2014), as well as Harvard-affiliated institutions (Brigham and Women’s, Massachusetts General, Dana-Farber; 2019). Research Interests: Focuses on clinical trials, biomarker development, and response assessment of systemic therapies in solid tumors, particularly pancreatic cancer. Leads the Alliance A021806 trial, the largest pancreatic cancer trial in North America, and chairs the NCI GI Steering Committee’s Pancreas Task Force. Clinical Trials: Active trial Alliance A021806 evaluates perioperative chemotherapy for resectable pancreatic cancer. Enrollment criteria include adults with resectable pancreatic cancer. Locations: Chicago, IL. Recipient of NCI’s R50 Award for clinical trial infrastructure expansion. Directs the Northwestern Medicine Surgical Oncology Tumor Bank and Translational Research Laboratory. Awards & Leadership: Multiple mentorship awards (2022–2024), invited roles on national committees (e.g., NCI Liquid Biopsy Task Force), and editorial roles at Annals of Surgical Oncology and Frontiers in Oncology .

• Surgical Oncology
• Pancreatic Cancer
• Clinical Trials
• +۳ مورد دیگر

Dr. Tim Halim is a Sir Henry Dale Fellow and Junior Group Leader at the Cancer Research UK Cambridge Institute (CRUK Cambridge Institute), University of Cambridge. His primary research program focuses on pancreatic cancer, with thoracic cancer as a secondary research focus within the CRUK Cambridge Centre's structured research programs. Dr. Halim's research expertise lies at the intersection of cancer biology and immunology, with particular emphasis on innate lymphoid cells (especially ILC2) and regulatory T cells within the tumor microenvironment. His work investigates how these immune cell populations interact with cancer cells and influence tumor progression, metastasis, and response to therapy. His research has significant implications for developing novel immunotherapeutic approaches for pancreatic and thoracic cancers. His publication record demonstrates a consistent focus on the role of innate lymphoid cells in cancer, with recent work examining IL-33 and ILC2 in pancreatic cancer, cross-talk between ILC2 and regulatory T cells, and the influence of innate lymphoid cells on pancreatic stromal composition. His research employs advanced techniques including in vivo labeling, single-cell analysis, and fate-mapping approaches to understand immune cell behavior in cancer contexts. Dr. Halim has been awarded the prestigious Sir Henry Dale Fellowship, a joint fellowship from the Royal Society and Wellcome Trust that supports early-career researchers of outstanding promise working at the interface of basic and clinical science.

• Cancer Immunology
• Innate Lymphoid Cells
• Regulatory T Cells
• +۵ مورد دیگر

John Bagterp Jørgensen is a Professor at the Department of Applied Mathematics and Computer Science, Technical University of Denmark (DTU). His research focuses on computational methods for Model Predictive Control (MPC), numerical optimization, and dynamic optimization, with applications in industrial processes, biomedical systems, and sustainable energy. He holds leadership roles in 2-control ApS, a company developing advanced control solutions for industries such as cement production and oil recovery. Education: PhD and M.Sc. in Technical Sciences from DTU (1997–2005 and 1991–1997). Professional experience includes roles as an Assistant Professor at DTU and CTO/CEO at 2-control ApS. Research interests span MPC algorithms, numerical methods for differential equations, and system identification. His work bridges academia and industry, addressing challenges in energy efficiency, vaccine manufacturing, diabetes treatment, and cement production processes. His recent articles emphasize industrial applications of control systems, including cement rotary kiln dynamics, vaccine production optimization, and dual-hormone artificial pancreas development. He has received the Nordic Energy Research Award (1994) and contributed to UN Sustainable Development Goals related to affordable energy and industrial innovation. Advising and grants: Supervises multiple PhD projects on topics like electrification of industrial processes and sustainable SCP production. Collaborates with global institutions on energy and biomedical research. Labs/teams: Leads teams in DTU’s Scientific Computing and Center for Energy Resources Engineering, with active partnerships in industry and academia.

• Model Predictive Control
• Numerical Optimization
• Process Control
• +۵ مورد دیگر

Dr. Kathryn A. Whitehead is a Professor in the Department of Chemical Engineering and holds a courtesy appointment in the Department of Biomedical Engineering at Carnegie Mellon University. She joined the faculty in 2012 after completing postdoctoral training at MIT. Her research focuses on engineering drug delivery systems for RNA therapeutics, maternal-infant health, and overcoming biological barriers to enhance drug efficacy. Key areas include lipid nanoparticle (LNP) design for mRNA delivery, intestinal permeation enhancement, and leveraging maternal milk cells for therapeutic applications. Education: H.B.Ch.E., University of Delaware (2002); Ph.D., University of California, Santa Barbara (2007); Postdoctoral Fellow, MIT (2008–2012). Research Interests: Drug delivery systems, RNA interference, bionanotechnology, personalized medicine, and translational nanomedicine for diseases such as cancer and diabetes. Her lab develops novel LNPs for targeted delivery to tissues like the liver, brain, and pancreas. Awards and Recognition: AIMBE Fellow, DARPA Young Faculty Award (2016), CMBE Young Innovator Award (2016), MIT Technology Review Innovator Under 35 (2014), and NIH Director’s New Innovator Award. Her work has been cited over 9,000 times, with patents in RNA delivery and permeation enhancers. Lab Members: Active researchers include Ph.D. students, postdocs, and undergraduates working on projects such as LNP formulation, maternal milk cell biology, and siRNA therapies. Notable alumni have advanced to roles at Moderna Therapeutics, Verve Therapeutics, and academic institutions. Grants and Funding: Supported by NIH, DARPA, and industry partnerships. Current projects include NIH grants on pregnancy-safe mRNA delivery and DARPA funding for maternal-infant therapeutics.

• Drug Delivery
• RNA Therapeutics
• Bionanotechnology
• +۴ مورد دیگر

Maria Golson, PhD, is an Assistant Professor of Medicine in the Division of Endocrinology, Obesity and Metabolism at the Johns Hopkins School of Medicine. She joined the institution in 2020 and leads research focused on the intrinsic and extrinsic regulation of beta-cell function and insulin secretion. Her work is central to understanding pancreatic endocrine cell development and its implications in diabetes. Education: B.S. in Biology (Genetics concentration), Duke University, 2000 Ph.D. in Cell and Molecular Biology (Genetics and Gene Regulation), University of Pennsylvania, 2008 Postdoctoral Training, Vanderbilt University Dr. Golson's research spans molecular mechanisms of beta-cell function, epigenetic regulation in diabetes, and single-cell analysis of pancreatic islets. She employs advanced genomic and epigenomic tools to explore cellular states in both type 1 and type 2 diabetes, with a focus on identifying pathways that could be targeted for regeneration or functional enhancement of insulin-producing cells. Her recent publications, appearing in journals such as Nature Metabolism and Diabetes , reflect a strong trend toward multiomics and single-cell technologies to uncover novel cellular states in human islets. These studies integrate transcriptomics, epigenetics, and functional validation to dissect disease mechanisms. Dr. Golson has been supported by institutional affiliations and collaborations, including membership in the HPAP Consortium and the American Diabetes Association. While no formal awards are listed, her publication record indicates significant scientific contributions. She has mentored researchers through collaborative projects, though no formal advisees are named. Her lab engages in interdisciplinary research involving genetics, molecular biology, and bioinformatics to advance diabetes therapeutics.

• Endocrinology
• Beta-cell Function
• Insulin Secretion
• +۶ مورد دیگر

Clifford W. Bogue, MD , is the Waldemar Von Zedtwitz Professor of Pediatrics, Chair of the Department of Pediatrics at Yale School of Medicine, and Chief of Pediatrics for the Yale New Haven Health System. He has been a faculty member at Yale since 1993 and has held numerous leadership roles, including Interim Chairman of Pediatrics, Chief Medical Officer of Yale-New Haven Children’s Hospital, and Director of Pediatric Critical Care programs. Education: BA and MD from the University of Virginia; Residency and Chief Residency at Vanderbilt University; Fellowship in Pediatric Critical Care at Yale. Dr. Bogue is a pediatric critical care specialist whose research centers on the molecular mechanisms of organ development, particularly the role of the Hhex gene in liver, cardiovascular, and lung organogenesis. His lab used mouse models to uncover critical genetic pathways in embryonic development, with implications for regenerative medicine. His recent work also extends into pediatric public health, critical care infrastructure, and health equity. An analysis of his recent publications reveals a sustained focus on developmental genetics, with increasing engagement in clinical and policy-oriented research in pediatrics. His work spans molecular biology, translational models, and national health initiatives, reflecting a broad scholarly impact. His scientific honors include: President of the American Pediatric Society (2024–2025) Norman J. Siegel Faculty Award Marna P. Borgstrom Lifetime Achievement Award Consistent recognition in Best Doctors in America since 2004 Honorary M.A. from Yale University Dr. Bogue has been deeply involved in training the next generation of physician-scientists, serving as PI of an NIH T32 program, Training Director of the Yale Child Health Research Center (K12), and mentor in the MD/PhD program. He has contributed to national pediatric research policy through roles in the American Academy of Pediatrics, NIH advisory committees, and the Charles H. Hood Foundation. He leads or has led significant research initiatives, including an NIH-funded program on cardiopulmonary development and the Bedside to Bench seminar for medical students. His leadership extends to national boards and editorial roles, including Section Editor for Current Opinion in Pediatrics .

• Pediatric Critical Care Medicine
• Developmental Biology
• Organogenesis
• +۷ مورد دیگر

Professor Pantelis Georgiou holds a faculty position in the Department of Electrical and Electronic Engineering at Imperial College London, leading the Bio-inspired Metabolic Technology Laboratory within the Centre for Bio-Inspired Technology. His research focuses on biomedical electronics, lab-on-chip technology, and micro-electronic medical devices. Key contributions include the bio-inspired artificial pancreas for diabetes treatment and CMOS-based pH sensors for DNA sequencing and infectious disease diagnostics. Education: 1st Class Honours MEng (2004) and PhD (2008) in Electrical & Electronic Engineering from Imperial College London. Professional roles include Head of Lab (2010), IEEE Distinguished Lecturer in Circuits and Systems, and Co-founder/Director of ProtonDx. Research interests span ultra-low power microelectronics, bio-inspired circuits, wearable technologies for chronic conditions, and antimicrobial resistance diagnostics. He has pioneered ISFET sensor integration and developed rapid diagnostic platforms for infectious diseases like dengue and mpox. Notable awards include the IET Mike Sergeant Medal (2013) and IEEE Sensors Council Technical Achievement Award (2017). Current projects involve AI-driven clinical decision support systems, antibiotic stewardship tools, and global health technologies for resource-limited settings. Affiliations include the CRUK Convergence Science Centre, Organ-on-chip Network, and Imperial College Network of Excellence in Malaria. His work bridges engineering and medicine, addressing global challenges through interdisciplinary innovation.

• Biomedical Engineering
• Medical Diagnostics
• Microelectronics
• +۴ مورد دیگر

David Tosh is a Professor in the Department of Life Sciences at the University of Bath. His research focuses on cellular reprogramming, developmental biology, and regenerative medicine, with applications to cancer and stem cell therapy. He leads a lab investigating cell type conversions (e.g., pancreatic to liver cells) and their implications for disease like Barrett’s metaplasia. Current lab members include Heather Bone, Christopher Brimson, Zoe Burke, and others listed in the text. He collaborates on projects such as the NextGen-O2k High-Resolution Respirometry initiative and contributes to animal-free 3D tissue modeling. Key research themes include understanding transcription factors driving cell fate decisions, translational applications of reprogramming for therapy, and links between cellular plasticity and cancer progression. His work aligns with UN Sustainable Development Goals related to health and innovation.

• Cellular Reprogramming
• Developmental Biology
• Stem Cell Therapy
• +۳ مورد دیگر

Nancy Papalopulu is Professor of Developmental Neuroscience in the Faculty of Life Sciences at the University of Manchester, where she leads research on cell state transitions and gene expression dynamics during development. Currently holding a Wellcome Trust Investigator Award (2022-2027), she has been a prominent figure in developmental neuroscience for over two decades, previously serving as a Wellcome Trust Senior Research Fellow from 2006-2022 and at the Wellcome Trust/Cancer Research UK Gurdon Institute in Cambridge from 2000-2006. Her research focuses on understanding how cells transition from progenitor states to differentiation with precise timing, or enter quiescence from which they may be reactivated. Using single cell quantitative approaches, live imaging, multiple experimental model systems (including Xenopus, zebrafish, and stem cell cultures), and mathematical modeling, her lab investigates the dynamics of gene expression that underlie cell fate decisions. A key contribution has been the hypothesis that the mutually antagonistic interaction between the neural progenitor transcription factor Hes1 and microRNA miR-9 generates pulsatile gene expression at the single cell level, which can transition to stable states in a time-controlled manner. Analysis of her recent publications reveals a strong focus on oscillatory gene expression patterns, neural development mechanisms, and the role of dynamics in cell fate determination. Her work spans developmental neuroscience, cancer biology (particularly glioblastoma), and pancreatic development, demonstrating the broad applicability of her research on gene expression dynamics. Scientific Awards and Recognition: Wellcome Trust Investigator Award (2022-2027) Wellcome Trust Senior Research Fellow (2006-2022) Wellcome Trust Senior Research Fellow (2000-2006) Wellcome Trust Career Development Fellow (1997-2000) Post-doctoral Fellow, Human Frontier Science Program Organization (1991-1996) Professor Papalopulu supervises multiple PhD students and postdoctoral researchers through various funding mechanisms including Wellcome Trust, MRC, and CRUK. Her current projects include 'A quantitative and dynamical approach to understanding cell state transitions' (2022-2027), 'Decoding Pulsing Proteins in the Pancreas' (2018-2022), and participation in the Centre for Biological Timing. Her laboratory team consists of postdocs, PhD students, and technicians working collaboratively on multiple aspects of developmental dynamics. The Papalopulu Lab maintains a strong presence in the field with 88 research outputs and active collaborations across multiple institutions. Her work contributes to UN Sustainable Development Goals related to good health and well-being through advancing fundamental understanding of developmental processes that underlie tissue formation, maintenance, and disease.

• Developmental Neuroscience
• Cell State Transitions
• Gene Expression Dynamics
• +۳ مورد دیگر

Maud Frieden is an Associate Professor at the Department of Cell Physiology and Metabolism, University of Geneva. Her lab focuses on skeletal muscle regeneration mechanisms using human stem cell models. Key research areas include muscle satellite cell activation, calcium signaling pathways, and the molecular basis of muscle diseases like myopathies. Research Interests: Frieden’s work investigates how muscle stem cells (satellite cells) repair damaged muscle tissue. Recent projects explore store-operated calcium entry (SOCE) pathways in muscle differentiation and the role of mitochondrial dysfunction in muscle atrophy. Advanced in vitro models are used to study human myotube maturation and disease mechanisms. Lab Team: Current members include PhD students Jessica Brunetti and Julie Perroud, postdoc Axel Tollance, and lab technician Olivier Dupont. The team collaborates with experts in proteomics (e.g., Eckhardt et al., 2023) and cardiac physiology (Rusiecka et al., 2023). Publications: Recent work highlights ER stress-IRE1 interactions in muscle regeneration (Carreras Sureda et al., 2023) and TRPC channel roles in myogenesis (Antigny et al., 2013-2022). Over 30 peer-reviewed articles span muscle biology, calcium signaling, and stem cell research.

• Cell Physiology
• Muscle Regeneration
• Stem Cell Biology
• +۳ مورد دیگر

John S. Kaddis, Ph.D. is an Associate Professor in the Department of Diabetes & Cancer Discovery Science within the Arthur Riggs Diabetes & Metabolism Research Institute at City of Hope. With over 15 years of experience at City of Hope, Dr. Kaddis has developed scientific resources for team-based research initiatives focused on type 1 diabetes, creating data systems, analysis tools, and websites used by researchers worldwide. Dr. Kaddis earned his B.S. (Honors) in Biochemistry from California State University Los Angeles, where he completed undergraduate research supported by two National Science Foundation fellowships. He later earned his Ph.D. in Systems Biology and Disease from the University of Southern California. His academic journey includes positions as Assistant Professor since 2015 and Associate Professor since 2022 at City of Hope. Dr. Kaddis's research primarily focuses on the complex mechanisms of type 1 diabetes through systems biology and bioinformatics approaches. His work centers on understanding islet cell biology, beta cell dysfunction, and the immunological aspects of type 1 diabetes. His research has evolved from developing collaborative data resources to conducting cutting-edge investigations into genetic factors in diabetes pathogenesis. He has pioneered the creation of bioinformatics platforms that enable global collaboration in diabetes research. The trends in Dr. Kaddis's publications reveal a progression from foundational work on biobanking and data management toward increasingly sophisticated investigations of genetic and immunological mechanisms in type 1 diabetes. His recent work emphasizes translational applications, including potential therapeutic strategies and predictive models that span diverse ancestral backgrounds. His research bridges basic science with clinical applications through the Human Islet Research Network. Member, American Association for the Advancement of Science (2011-Present) Professional Member, American Diabetes Association (2010-Present) Member, Society of Clinical Research Associates (2003-2012) Lifetime Member, Tri-Beta Honor Society (2000-Present) Dr. Kaddis serves as principal investigator and co-investigator on multiple NIH and JDRF-funded projects, including the Human Islet Research Network Bioinformatics Center and the JDRF nPOD DataShare initiative. His work has established critical infrastructure for collaborative diabetes research, enabling researchers worldwide to access and analyze complex datasets. His laboratory has developed specialized data management systems that facilitate the sharing of islet cell research data across international boundaries while maintaining appropriate security and privacy protections. Dr. Kaddis's athletic pursuits in marathons and triathlons mirror his research approach—requiring stamina and perseverance to achieve long-term goals in diabetes research.

• Type 1 Diabetes
• Systems Biology
• Bioinformatics
• +۵ مورد دیگر

Ala Trusina is an Associate Professor at the Niels Bohr Institute , University of Copenhagen , specializing in Biocomplexity and Biophysics . Her research integrates coarse-grained modeling to study complex biological systems. Key Research Areas Stress Response Systems (diabetes, aging, cancer, inflammation) Stem Cell Differentiation (cell fate coordination, reversibility of states) Complex Systems (species coexistence, epidemics, CRISPR-phage interactions) Methodologies Theoretical: Agent-based modeling, in-silico simulations Experimental: Quantitative single-cell imaging, RNA/protein profiling Collaborations Joshua Brickman (ES cells), Anne Grapin-Botton (pancreas), Feroz Papa (diabetes), Else Kai Hoffman (p53 dynamics) Thomas Mandrup-Poulsen (inflammation), Savas Tay (spatio-temporal regulation) Teaching Physics of Molecular Diseases Numerical Methods in Physics

• Systems Biology
• Stress Response
• Stem Cell Differentiation
• +۳ مورد دیگر

Dr. Oliver Double is a Senior Lecturer in Comic and Popular Performance at the University of Kent, where he has taught since 1999. He specializes in stand-up comedy, alternative comedy, and variety theatre, with a focus on first-person audience engagement and historical analysis. As Deputy Head of School, he contributes to academic leadership while maintaining an active research profile. Established the British Stand-Up Comedy Archive (BSUCA) at Templeman Library, Canterbury Interviews Editor of Comedy Studies journal His research explores direct performer-audience dynamics, including works on Karl Valentin, Brechtian cabaret, and punk rock's theatrical dimensions. Key themes include comedy's sociocultural impact, performance authenticity, and the transformation of personal experiences into material. Recent publications analyze Laura Lexx's mental health narratives, tracing terminology origins of stand-up, and examining rehearsal processes. His teaching integrates archival resources and performance theory, preparing students for careers in comedy and related fields. Active in public scholarship, he contributes to documentaries and maintains an ongoing creative practice through the Funny Rabbit comedy club and solo performances like Break a Leg (2015) and Saint Pancreas (2006).

• Stand-up Comedy
• Alternative Comedy
• Variety Theatre
• +۴ مورد دیگر